Skip to main content

MEJORA DEL SISTEMA DE AYUDA AL DIAGNOSTICO PARA PREDECIR EL GRADO DE RETINOPATIA DIABETICA Y EN CASO DE RETINOPATIA LEVE PREDECIR LA EVOLUCION A FASES MAS AVANZADAS

PI21/00064

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION SANITARIA PERE VIRGILI
Execution centre HOSPITAL SAN JUAN DE REUS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Referable Diabetic Retinopathy Prediction Algorithm Applied to a Population of 120,389 Type 2 Diabetics over 11 Years Follow-Up

  • Romero-Aroca, P.|||0000-0002-7061-8987
  • Verges, Raquel
  • Pascual-Fontanilles, Jordi|||0000-0002-7528-5819
  • Valls-Mateu, Aida|||0000-0003-3616-7809
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Moreno-Ribas, Antonio|||0000-0003-3945-2314
  • Basora, Josep|||0000-0003-0278-1149
  • Garcia-Curto, Eugeni
  • Baget-Bernaldiz, Marc
(1) Background: Although DR screening is effective, one of its most significant problems is a lack of attendance. The aim of the present study was to demonstrate the effectiveness of our algorithm in predicting the development of any type of DR and referable DR. (2) Methods: A retrospective study with an 11-year follow-up of a population of 120,389 T2DM patients was undertaken. (3) Results: Applying the results of the algorithm showed an AUC of 0.93 (95% CI, 0.92-0.94) for any DR and 0.90 (95% CI, 0.89-0.91) for referable DR. Therefore, we achieved a promising level of agreement when applying our algorithm. (4) Conclusions: The algorithm is useful for predicting which patients may develop referable forms of DR and also any type of DR. This would allow a personalized screening plan to be drawn up for each patient.